Steady concentration PD with the Carry Life UF system increased ultrafiltration nearly threefold and sodium removal nearly tenfold vs 2.5% dextrose CAPD, while improving glucose efficiency and supporting enhanced fluid management in PD patients

Contributed by: Business Wire

Logo

Tags

Research

Medical Devices

Diabetes

Clinical Trials

Other Health

Health

General Health

Other Science

Science

Triomed AB

More Like This

Vantive Highlights Late-Breaking High Clinical Impact Data at ERA Indicating HDx Therapy is a Practical Alternative to Online Hemodiafiltration

New Health Economic Evidence Shows Health & Cost Benefits When Starting Dialysis at Home

Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation

PR Newswire associated0

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

PR Newswire associated0

Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life's VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology

PR Newswire associated0

Claros Technologies Successfully Demonstrates High-Throughput PFAS Destruction in Landmark Pilot

PR Newswire associated0

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs